The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
Book
This book was written to enhance the strategic contributions of the healthcare supply chain in a way that is most meaningful to hospitals’ an
White Papers
AHRMM19 CQO Summit White Paper entitled CQO: The Power of Clinical Integration.
On-Demand Educational Webinars
In this webinar, we discuss the clinical contract evaluation process, including government requirements, expectations, and improving contract…
Podcasts
A thought-leader panel discussion about the role of GPOs within the changing healthcare landscape and the and the daily decision of using a GPO or
On-Demand Educational Webinars
Learn about a comprehensive assessment and process improvement exercise on the Total Cost of Ownership model by UPMC and Cook Medical. Specific areas…
Webcast
Continuing from Part 1, this short session updates supply chain professionals on the design and timing of the new small bore tubing connectors maki